title: Suppressor of cytokine signal 3 and IL28 genetic variation predict the viral response to peginterferon and ribavirin.
abstract: OBJECTIVE
  The aim of this study was to investigate the relationship among the expression of suppressor of cytokine signaling 3 (SOCS 3) in the liver, the SNPs in the IL28B locus, and the outcome of interferon therapy.
  
  
  METHODS
  Prior to interferon treatment, we immunostained 67 liver specimens from chronic hepatitis C (CHC) patients who were receiving peginterferon alpha-2b/ribavirin therapy for suppressor of cytokine signaling 3 (SOCS3), and compared the expression of SOCS3, IL28 polymorphisms and other clinical factors between the patients and compared their eventual outcomes.
  
  
  RESULTS
  Significant differences between the low SOCS3 group and high SOCS3 group were found in age, as well as in the platelet, transaminase, gamma-glutamyl transpeptidase levels. The incidence of high SOCS3 was not significantly different between subjects with the TT genotype and the TG genotype (TT : TG = 71%:29%, P = 0.250). In a multivariate analysis, age (≥65 years old) (odds ratio 0.221 [0.120-0.966], P = 0.045), IL28B gene (genotype TT) (odds ratio 5.422 [1.254-23.617], P = 0.024) and SOCS3 (high) (odds ratio 0.308 [0.104-0.948], P = 0.040) were significant predictors of the interferon response. In patients with the TT genotype, those with low SOCS3 immunostaining showed a high sustained virological response (69%), while the sustained virological rate was low (27%) in the patients with high SOCS3 immunostaining.
  
  
  CONCLUSIONS
  Using a combination of the SOCS3 immunostained area in the liver and the expression of IL28B single nucleotide polymorphisms might be a useful predictor of hepatitis C virus clearance by interferon therapy.
authors: Department of Gastroenterology and Hepatology, Nagasaki University School of Medicine             Central Diagnostic Laboratory of Nagasaki University Hospital, Nagasaki             Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center, Omura             Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya             Research Center for Hepatitis and Immunology, International Medical Center of Japan, Konodai Hospital, Ichikawa, Japan.
authors: Hisamitsu
authors: H
authors: Miyaaki
authors: Tatsuki
authors: T
authors: Ichikawa
authors: Hiroshi
authors: H
authors: Yatsuhashi
authors: Naota
authors: N
authors: Taura
authors: Satoshi
authors: S
authors: Miuma
authors: Tetsuya
authors: T
authors: Usui
authors: Sayaka
authors: S
authors: Mori
authors: Shimeru
authors: S
authors: Kamihira
authors: Yasuhito
authors: Y
authors: Tanaka
authors: Masashi
authors: M
authors: Mizokami
authors: Kazuhiko
authors: K
authors: Nakao